Akero (AKRO) CEO gifts 14,739 shares; ownership now 511,375

Akero Therapeutics (AKRO) reported an insider transaction by its President and CEO, who is also a Director.

Rhea-AI Filing Summary

Akero Therapeutics (AKRO) reported an insider transaction by its President and CEO, who is also a Director. On 11/12/2025, the insider made a bona fide charitable gift of 14,739 shares of common stock, reported as code G at a stated price of $0. Following the transaction, the insider’s beneficial ownership stands at 511,375 shares, held directly.

The explanation notes the recipient is a 501(c)(3) organization and the reporting person has no pecuniary interest in that entity.

Insider Trade Summary

14,739 shares gifted

Gift 1 txn

Insider Cheng Andrew

Role President and CEO

Type	Security	Shares	Price	Value
Gift	Common Stock	14,739	$0.00	$0.00

Holdings After Transaction: Common Stock — 511,375 shares (Direct)

Footnotes (1)

1. F1. The reported transaction represents a bona fide charitable gift to a 501(c)(3) organization. The Reporting Person does not have any pecuniary interest in the 501(c)(3) organization.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Akero Therapeutics (AKRO) disclose in this Form 4?

An insider reported a bona fide charitable gift of 14,739 shares on 11/12/2025.

Who is the reporting person in the AKRO filing?

Akero’s President and CEO, who also serves as a Director.

How many shares does the insider hold after the transaction?

The insider beneficially owns 511,375 shares directly after the reported gift.

What does transaction code G mean in this context?

Code G indicates a bona fide gift; the filing specifies a charitable gift to a 501(c)(3).

Was any price reported for the gifted shares?

Yes. The transaction lists a price of $0, which is standard for gifts.

Does the reporting person have economic interest in the recipient?

No. The filing states the reporting person has no pecuniary interest in the 501(c)(3) organization.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/13/2025 - 08:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cheng Andrew

(Last) (First) (Middle)

C/O AKERO THERAPEUTICS, INC.

601 GATEWAY BOULEVARD, SUITE 350

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Akero Therapeutics, Inc. [ AKRO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/12/2025		G(1)		14,739	D	$0	511,375	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction represents a bona fide charitable gift to a 501(c)(3) organization. The Reporting Person does not have any pecuniary interest in the 501(c)(3) organization.

	/s/ Jonathan Young, Attorney-in-Fact	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.